Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Diagnostics
In Vitro Diagnostics
Return to: MDBR Home | Diagnostics | In Vitro Diagnostics | News
Search Refinements

In Vitro Diagnostics News

View news from other Medical Devices sectors:
91-105 of 2945 results
Clinical Genomics launches blood-based test for CRC recurrence monitoring
By MDBR Staff Writer
Clinical Genomics has introduced a new a blood-based test for colorectal cancer (CRC) recurrence monitoring.
Diagnostics > In Vitro Diagnostics > News
Cepheid gets FDA approval for next generation MRSA infection control test
By MDBR Staff Writer
Cepheid has secured approval from the US Food and Drug Administration (FDA) for its next generation methicillin-resistant Staphylococcus aureus (MRSA) infection control test, Xpert MRSA NxG.
Diagnostics > In Vitro Diagnostics > News
HiberGene gets CE mark approval for HG C. difficile test
By MDBR Staff Writer
Ireland-based HiberGene Diagnostics has secured CE mark approval for its HG C. difficile test.
Diagnostics > In Vitro Diagnostics > News
Med-IQ, MedStar Health partner to improve HCV testing and linkage to specialty care
The Med-IQ Quality Improvement Institute has joined forces with MedStar Health, the healthcare provider in Maryland and Washington, DC, to address the substantial burden of unrecognized chronic hepatitis C virus (HCV) infection among the baby boomer population.
Diagnostics > In Vitro Diagnostics > News
Oxford Gene Technology introduces three new Cytocell Aquarius FISH probes
Oxford Gene Technology (OGT) has expanded its Cytocell sarcoma fluorescence in situ hybridisation (FISH) probe range with three new products.
Diagnostics > In Vitro Diagnostics > News
PROTAGEN launches NavigAID assay to support clinical drug development for autoimmune diseases
PROTAGEN has launched NavigAID SSc, a disease stratification assay designed to support pharmaceutical and biotechnology companies with their Systemic Sclerosis (SSc) drug development efforts.
Diagnostics > In Vitro Diagnostics > News
Siemens Healthineers to invest $300m in US laboratory diagnostics manufacturing facility
By MDBR Staff Writer
Siemens Healthineers is investing $300m in Walpole, Massachusetts laboratory diagnostics manufacturing facility over the next four years.
Diagnostics > In Vitro Diagnostics > News
Grifols to acquire Hologic’s blood screening business for $1.85bn
By MDBR Staff Writer
Spanish healthcare firm Grifols has agreed to acquire blood screening business from its partner Hologic for around $1.85bn.
Diagnostics > In Vitro Diagnostics > News
ITL BioMedical signs distribution agreement with bioMérieux Canada
ITL BioMedical, a division of ITL, announced that it has signed a five year distribution agreement, with possible ongoing renewals, for its Safety SubCulture Unit (SCU) with bioMérieux Canada.
Diagnostics > In Vitro Diagnostics > News
Nanomix advances rapid diagnostic panel to aid emergency evaluation of sepsis
Nanomix revealed the first rapid diagnostic test panel designed to quickly evaluate patients affected by sepsis, which runs on the company's simple-to-use, handheld diagnostic system, the Nanomix eLab.
Diagnostics > In Vitro Diagnostics > News
Trovagene announces reorganization to accelerate global distribution of liquid biopsy technology
Trovagene, a developer of circulating tumor DNA (ctDNA) molecular diagnostics, announced that it will increase its focus on the global distribution of kits and systems to clinical research laboratories for the liquid biopsy oncology testing market.
Diagnostics > In Vitro Diagnostics > News
Curetis acquires qPCR-based Gyronimo platform from Carpegen and Systec
By MDBR Staff Writer
Molecular diagnostic solutions provider Curetis has acquired real-time qPCR-based Gyronimo platform from Carpegen and Systec.
Diagnostics > In Vitro Diagnostics > News
Cancer Targeted Technology begins Phase I clinical trial of CTT1057 diagnostic imaging agent for prostate cancer
Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on small molecules that target pivotal enzyme targets on cancer, announced that a Phase I clinical trial has commenced in men with high risk metastatic prostate cancer.
Diagnostics > In Vitro Diagnostics > News
Pacific Edge introduces Cxbladder Monitor urine-based gene expression test in US
By MDBR Staff Writer
Cancer diagnostics firm Pacific Edge has introduced Cxbladder Monitor urine-based gene expression test in the US.
Diagnostics > In Vitro Diagnostics > News
Apax Partners acquires Unilabs from Nordic Capital and Apax Partners France
By MDBR Staff Writer
Apax Partners has acquired Switzerland-based medical diagnostic provider Unilabs from Nordic Capital and Apax Partners France.
Diagnostics > In Vitro Diagnostics > News
91-105 of 2945 results